Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Blood–brain barrier structure and function and the challenges for CNS drug delivery
NJ Abbott - Journal of inherited metabolic disease, 2013 - Springer
The neurons of the central nervous system (CNS) require precise control of their bathing
microenvironment for optimal function, and an important element in this control is the blood …
microenvironment for optimal function, and an important element in this control is the blood …
Human positron emission tomography neuroimaging
Neuroimaging with positron emission tomography (PET) is the most powerful tool for
understanding pharmacology, neurochemistry, and pathology in the living human brain. This …
understanding pharmacology, neurochemistry, and pathology in the living human brain. This …
Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood–brain barrier penetration …
An accurate means of predicting blood–brain barrier (BBB) penetration and blood–brain
partitioning of NCEs (new chemical entities) would fulfill a major need in pharmaceutical …
partitioning of NCEs (new chemical entities) would fulfill a major need in pharmaceutical …
Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier
The aim of this study was to investigate the ability of a third-generation (G3) polyamidoamine
(PAMAM) dendrimer-based carrier to enhance the permeability of paclitaxel (pac) and to …
(PAMAM) dendrimer-based carrier to enhance the permeability of paclitaxel (pac) and to …
Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept
A Reichel - Chemistry & biodiversity, 2009 - Wiley Online Library
Despite enormous efforts, achieving a safe and efficacious concentration profile in the brain
remains one of the big challenges in central nervous system (CNS) drug discovery and …
remains one of the big challenges in central nervous system (CNS) drug discovery and …
Targeting inflammation and wound healing by opioids
C Stein, S Küchler - Trends in pharmacological sciences, 2013 - cell.com
Opioid receptors are expressed on peripheral sensory nerve endings, cutaneous cells, and
immune cells; and local application of opioids is used for the treatment of inflammatory pain …
immune cells; and local application of opioids is used for the treatment of inflammatory pain …
Physiologically based pharmacokinetic modeling to investigate regional brain distribution kinetics in rats
J Westerhout, B Ploeger, J Smeets, M Danhof… - The AAPS journal, 2012 - Springer
One of the major challenges in the development of central nervous system (CNS)-targeted
drugs is predicting CNS exposure in human from preclinical data. In this study, we present a …
drugs is predicting CNS exposure in human from preclinical data. In this study, we present a …
In Vivo Methods to Study Uptake of Nanoparticles into the Brain
Several in vivo techniques have been developed to study and measure the uptake of CNS
compounds into the brain. With these techniques, various parameters can be determined …
compounds into the brain. With these techniques, various parameters can be determined …
[HTML][HTML] A detailed method for preparation of a functional and flexible blood–brain barrier model using porcine brain endothelial cells
A Patabendige, RA Skinner, L Morgan, NJ Abbott - Brain research, 2013 - Elsevier
The blood–brain barrier (BBB) is formed by the endothelial cells of cerebral microvessels
and forms the critical interface regulating molecular flux between blood and brain. It …
and forms the critical interface regulating molecular flux between blood and brain. It …
[HTML][HTML] Preclinical alternative drug discovery programs for monogenic rare diseases. Should small molecules or gene therapy be used? The case of hereditary …
Highlights•We provide guidelines for drug discovery campaigns for rare Hereditary spastic
paraplegia (HSP).•Alternative models beyond traditional drug discovery paradigms are …
paraplegia (HSP).•Alternative models beyond traditional drug discovery paradigms are …